These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 26011979)
21. The effect of dissolved oxygen on the production and the glycosylation profile of recombinant human erythropoietin produced from CHO cells. Restelli V; Wang MD; Huzel N; Ethier M; Perreault H; Butler M Biotechnol Bioeng; 2006 Jun; 94(3):481-94. PubMed ID: 16523522 [TBL] [Abstract][Full Text] [Related]
22. Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor. Nagao M; Masuda S; Abe S; Ueda M; Sasaki R Biochem Biophys Res Commun; 1992 Oct; 188(2):888-97. PubMed ID: 1445329 [TBL] [Abstract][Full Text] [Related]
23. Effect of surfactant pluronic F-68 on CHO cell growth, metabolism, production, and glycosylation of human recombinant IFN-γ in mild operating conditions. Clincke MF; Guedon E; Yen FT; Ogier V; Roitel O; Goergen JL Biotechnol Prog; 2011; 27(1):181-90. PubMed ID: 21312365 [TBL] [Abstract][Full Text] [Related]
24. Engineering and expression of a secreted murine TCR with reduced N-linked glycosylation. Strong RK; Penny DM; Feldman RM; Weiner LP; Boniface JJ; Davis MM; Bjorkman PJ J Immunol; 1994 Nov; 153(9):4111-21. PubMed ID: 7930615 [TBL] [Abstract][Full Text] [Related]
25. Glycosylation-modified erythropoietin with improved half-life and biological activity. Su D; Zhao H; Xia H Int J Hematol; 2010 Mar; 91(2):238-44. PubMed ID: 20131103 [TBL] [Abstract][Full Text] [Related]
26. Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli. Wang YJ; Liu YD; Chen J; Hao SJ; Hu T; Ma GH; Su ZG Int J Pharm; 2010 Feb; 386(1-2):156-64. PubMed ID: 19932158 [TBL] [Abstract][Full Text] [Related]
27. Control of rHuEPO biological activity: the role of carbohydrate. Elliott S; Egrie J; Browne J; Lorenzini T; Busse L; Rogers N; Ponting I Exp Hematol; 2004 Dec; 32(12):1146-55. PubMed ID: 15588939 [TBL] [Abstract][Full Text] [Related]
28. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion. Wang J; Shen F; Yan W; Wu M; Ratnam M Biochemistry; 1997 Nov; 36(47):14583-92. PubMed ID: 9398177 [TBL] [Abstract][Full Text] [Related]
29. Appropriate mammalian expression systems for biopharmaceuticals. Werner RG; Noé W; Kopp K; Schlüter M Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718 [TBL] [Abstract][Full Text] [Related]
30. Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells. Xiao W; Li CQ; Xiao XP; Lin FZ Genet Mol Res; 2013 Dec; 12(4):6813-24. PubMed ID: 24391029 [TBL] [Abstract][Full Text] [Related]
31. Characterisation of a novel glycosylphosphatidylinositol-anchored mono-ADP-ribosyltransferase isoform in ovary cells. Stilla A; Di Paola S; Dani N; Krebs C; Arrizza A; Corda D; Haag F; Koch-Nolte F; Di Girolamo M Eur J Cell Biol; 2011 Aug; 90(8):665-77. PubMed ID: 21616557 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin: receptors and clinical use in rheumatoid arthritis. Krantz SB; Sawyer ST; Sawada K; Wolfe F; Bocagno J Int J Cell Cloning; 1990 Jan; 8 Suppl 1():181-95; discussion 195-8. PubMed ID: 2157776 [TBL] [Abstract][Full Text] [Related]
33. Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Yang M; Butler M Biotechnol Bioeng; 2000 May; 68(4):370-80. PubMed ID: 10745205 [TBL] [Abstract][Full Text] [Related]
34. Effect of tunicamycin treatment on ligand binding to the erythropoietin receptor: conversion from two classes of binding sites to a single class. Nagao M; Matsumoto S; Masuda S; Sasaki R Blood; 1993 May; 81(10):2503-10. PubMed ID: 8490167 [TBL] [Abstract][Full Text] [Related]
35. Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo). Llop E; Gutiérrez-Gallego R; Segura J; Mallorquí J; Pascual JA Anal Biochem; 2008 Dec; 383(2):243-54. PubMed ID: 18804089 [TBL] [Abstract][Full Text] [Related]
36. A single monoclonal antibody as probe to detect the entire set of native and partially unfolded rhEPO glycoforms. Amadeo I; Oggero M; Zenclussen ML; Robles L; Pereira D; Kratje R; Etcheverrigaray M J Immunol Methods; 2004 Oct; 293(1-2):191-205. PubMed ID: 15541288 [TBL] [Abstract][Full Text] [Related]
37. Isolation, primary structure characterization and identification of the glycosylation pattern of recombinant goldfish neurolin, a neuronal cell adhesion protein. Denzinger T; Diekmann H; Bruns K; Laessing U; Stuermer CA; Przybylski M J Mass Spectrom; 1999 Apr; 34(4):435-46. PubMed ID: 10226368 [TBL] [Abstract][Full Text] [Related]
38. Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production. Wang Q; Chung CY; Yang W; Yang G; Chough S; Chen Y; Yin B; Bhattacharya R; Hu Y; Saeui CT; Yarema KJ; Betenbaugh MJ; Zhang H Biotechnol J; 2019 Apr; 14(4):e1800186. PubMed ID: 30221828 [TBL] [Abstract][Full Text] [Related]
39. Expression and bioactivity of recombinant canine erythropoietin. MacLeod JN; Tetreault JW; Lorschy KA; Gu DN Am J Vet Res; 1998 Sep; 59(9):1144-8. PubMed ID: 9736393 [TBL] [Abstract][Full Text] [Related]
40. Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase. Werner A; Horstkorte R; Glanz D; Biskup K; Blanchard V; Berger M; Bork K Biol Chem; 2012 Aug; 393(8):777-83. PubMed ID: 22944680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]